Current portfolio
Acrux use in-house capabilities to develop and commercialise pharmaceutical products for global markets
Our vision is that our technology will enable 3D imaging to be cheaper, more widely available and truly portable throughout the world's clinics and hospitals.
ADC BIO is an innovative biotechnology company
Develops, manufactures and supplies digital health technologies
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform.
Focused on the development of bacteriophage for the treatment of bacterial infection
Developing novel drugs for inflamatory and immune diseases
Canary Medical Inc. develops medical implant and data management devices
Fast, accurate and early diagnoses brings benefits to patients, clinicians and healthcare providers.
Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™
Dedicated to the discovery, development and commercialisation of new antimicrobials
Design, development and manufacture of biomaterials for regenerative medical devices
FUNDAMENTAL SURGERY - the Flight Simulator for Surgeons
Predictive Genetics - Safeguarding your future
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report
Humanetix software automates administration through work-flow, giving users more time and energy for their most important tasks
Identifying disease through transcriptomics and mutation detection
Live Better With is here to make everyday living a little bit better for the millions of people living with cancer all over the world.
A New World of Diagnostics
myrecovery partners with leading orthopaedic surgeons to transform the patient journey every step of the way
Turning disabilities into superpowers
Nutrition and Technology Intelligence
Pioneer of the REX Robot that enhances the mobility of wheelchair users
Closed loop neuromodulation technology to record and measure electrical nerve signals
Manufacturer of high quality fish oils (omega-3 and omega-2)
Melbourne based medical informatics startup
Exited portfolio
Developing and commercialising specialty and generic topical pharmaceuticals
Drug development with FDA approved drug (fondaparinux) and oncology pipeline
Protein engineering technology platform to transform proteins into potent drug candidates
Regenerative products for the treatment of a broad range of wounds, scars and skin defects.
Making better treatments for cancer and central nervous system disorders
Now known as Aviragen Therapeutics, Inc. Focused on the development of direct-acting antivirals.
Committed to bringing science to wellbeing
Less-invasive, miniaturized, mechanical circulatory support technologies for advanced heart failure
Developing therapies for neurological disorders
PETization™ technology to develop novel biologic therapies for companion animals
Advancing and commercialising innovative medical dermatology products
Portfolio of inflammation and fibrosis products at various stages of development and approval